TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 157 participants.
Also called NCT05486832
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 157 participants
- Sponsor
- Cardiovalve Ltd.
- Registry
-
NCT05486832
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05486832. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-09 (actual); primary completion 2026-03-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System
- Acronym
- TARGET
- Condition
- Tricuspid Regurgitation
- Intervention (Device)
- Cardiovalve TR valve replacement System
- Lead sponsor
- Cardiovalve Ltd.
Record details
- Record id
cardio:ct-nct05486832- Content hash
e030b9a7603dfdc5f1c819921d4c39fcd3884036b7984043c60e256c3045727d